Debt-to-Equity Ratio

The Debt-to-Equity Ratio measures how much debt a company uses to finance its operations relative to shareholders' equity.

GSK’s current ratio of 1.07x means the company has $1.07 of debt for every $1.00 of equity, indicating moderate leverage. Compared to sector peers, this is well above the healthcare sector median of 0.45x, placing GSK in the 79th percentile — higher debt than 79% of similar companies. No trend data is available: the year-over-year and quarter-over-quarter changes are both listed as N/A, and there are no values for the last eight quarters. The high relative debt level implies greater financial risk than most peers, but without trend information, it is impossible to assess whether leverage is increasing or decreasing. This elevated Debt-to-Equity Ratio introduces a risk factor that leans against a bullish view, but the absence of trend data means it does not clearly contradict the overall NEUTRAL verdict on the stock.

Frequently Asked Questions

Closest Sector Peers